Education

Biography

IvánFernándezVega is a general pathologist. He has been working as a consultant since 2013 in the Pathology Department at Hospital Universitario de Araba (Basque Country) Spain reporting biopsies on hematopathology and neuropathology fields. He spent two months in the Hematopathology Department of University College Hospital in London (UK) as hematopathology training

Research Interest

Leukemia & Lymphoma and plasma cell tumors.

Professional Activities:

Awards

1. First Prize for the best scientific exhibits in the I CNPEM (Congreso Nacional de Pediatría para Estudiantes) Santander 2007.“Evolución de la somatometría de los niños de la ciudad de Oviedo en los últimos 14 años” Primer premio en las comunicaciones orales. I.Fernadez Vega,  M. Pipa Muñiz, L. Revuelta Mariño, A Zarauza Santoveña.
2. First Prize for the best oral scientific exhibition in the LXIII Reunión de la Sección Regional Asturiana-Cántabro-Castellano-Leonesa con la comunicación: “Lesiones cutáneas eruptivas en una gestante” por Noemí Eirís Salvado, Palacios-García, I. Fernández Vega, S. Gómez Díez y N. Pérez Oliva. May, 2011.
3. “Emilio Rodriguez Vigil” award at Hospital Universitario Central de Asturias, to the best scientific poster titled: Immunohistochemistry assay of  Bruton´s Tyrosine kinase in 388 lymphoproliferative neoplasm: A something more than a B-cell marker. Oviedo. May, 2013.

Publications

1. Granulocytic sarcoma of the small bowel, greater omentum and peritoneum associated with a CBFB/MYH11 fusion and inv (16) (p13q22): a case report. Paloma Álvarez, Carmen A Navascues, Carlos Ordieres, Maria Pipa, Iván F.Vega, José A. Álvarez, Manuel Rodríguez. (2011). International Archives of Medicine 201,14:3. Impact factor: 1,08
2. Clinical case: “Schwanoma sacro como causa de lumbociatalgia.” Argüelles Rodríguez C, Fernández Vega I, Diánez Raimúndez J, López-Anglada Fernández E, Braña Vigil A. Cirugía Ortopédica actual Volumen II. SACOT 2011. ISBN: 978-84-614-2002-5. Impact factor: No.
3. Giant hepatocellular carcinoma. Paloma Álvarez-Martínez, Pablo Granero-Castro, Iván Fernández-Vega, Alfredo Renilla-González, Luis Rodrigo-Sáez and María Varela-Calvo. REV ESP ENFERM DIG (Madrid Vol. 104. N.° 5, pp. 264-265, 2012. Impact factor: 1,548
4. Multiple lymphomatous polyposis of intestine as presentation of mantle cell lymphoma. Paloma Álvarez-Martínez, María Pipa-Muñiz, Carlos Ordieres-Díaz, Iván Fernández-Vega, María Antonia Palacio-Galán, Pablo Granero-Castro and Alfonso Suárez-González. REV ESP ENFERM DIG (Madrid) Vol. 104. N.° 9, pp. 491-492, 2012. Impact factor: 1,548
5. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer. Iván Fernández-Vega, Olivia García, Ainara Crespo, Sonia Castañón, Primitiva Menéndez, Aurora Astudillo, Luis M Quirós. BMC Cancer 2013, 13:24 doi:10.1186/1471-2407-13-24. Impact factor: 3.33
6. Epithelial-Myoepithelial carcinoma of parotic gland: A cytological challenge with histological correlation. Iván Fernández-Vega, Nelson Fuentes Martínez, Guillermo E Mendoza, Jorge Santos-Juanes and Florentino Fresno-Forcelledo. Journal of Cytology and Histology. Impact factor: 1,064.
7. Cardiac granulocytic sarcoma (chloroma). A rare cause of pericardial effusion. A. Renilla, I. Fernández-Vega, J. Santos-Juanes y J.M. de la Hera. Revista Clínica Española. 2013. Impact factor: 2,008.
8. Pulmonary artery sarcoma mimicking a pulmonary embolism. AlfredoRenilla, Ivan Fernandez-Vega, Marıa Martın and Jonathan W. Weinsaft. Eur Heart J Cardiovasc Imaging. Impact factor: 2,394. 
9. Multiple alterations of Heparan sulphate in cancer. O. Garcia-Suarez, I. Fernández-Vega, L.M. Quirós. Article Review. OA CANCER. Impact factor: No
10. DNA methylation signatures identify biologically distinct thyroid cancer subtypes. The Journal of Clinical Endocrinology & Metabolism. Sandra Rodríguez-Rodero, Agustín F. Fernández, Juan Luís Fernández-Morera, Gustavo F. Bayon, Cecilia Ferrero, Rocío Gonzalez-Marquez, Iván Fernández-Vega, Manuel Florentino Fresno Forcelledo, Pablo Martínez-Camblor, Mercedes Robledo, Elías Delgado-Álvarez,  Edelmiro Menéndez-Torre and Mario F. Fraga. Impact factor: 6,5
11. Gliomatosis cerebri type 1 with extensive involvement of the spinal cord and BRAF V600E mutation. Pathology & Oncology Research.. Iván Fernández-Vega, Jennifer Quirk, Fiona L. Norwood, Naomi A. Sibtain, Ross Laxton, Istvan Bodi. Impact factor: 1.55
12. Neuroendocrine tumors show altered expression of chondroitin sulfate, glypican 1, glypican 5, and syndecan 2 depending on their differentiation grade. Frontiers in Oncology. Olivia García-Suarez, Beatríz García, Iván Fernández-Vega, Aurora Astudillo, Luis M.Quirós. 2014. Impact factor: No
13. Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer. Iván Fernández-Vega, Olivia García, Ainara Crespo, Sonia Castañón, Primitiva Menéndez, Aurora Astudillo, Luis M Quirós.
14. World Biomedical Frontiers. (Cancer) March 2014. ISSN: 2328-0166 Impact factor: No
15. Cutaneous Rosai-Dorfman disease following a classical Hodgkin lymphoma, nodular sclerosis subtype.. Fernandez-Vega I, Santos-Juanes J, Ramsay A. Am J Dermatopathol. 2014 Mar;36(3):280-1. Impact factor 1.418 
16. Cutaneous spread of primary neuroendocrine breast carcinoma with apocrine differentiation.. Santos-Juanes J, Fernández-Vega I, Coto-Segura P, Vivanco-Allende B, García-Pravia C. J Eur Acad Dermatol Venereol. 2014 Mar 24. Impact factor: 3.105
17. Perivascular Basophilic Rim as a Histopathological Clue of Cutaneous Pseudomona aeruginosa Sepsis. Santos-Juanes J, Fernández-Vega I, Vivanco-Allende B, Fresno Forcelledo M. Am J Dermatopathol. 2014 Jul 15. PMID:25033010. Impact factor: 1.418
18. Combined radical prostatectomy and abdominoperineal resection for locally invasive rectal cancer. Fernández-Martinez D, Rodriguez-Infante A, Castelo-Alvarez E, Fernandez-Vega I, Suárez-Hevia M, Truán-Alonso N, Baldonedo-Cernuda RF, Álvarez-Pérez JA, Sánchez-Farpón H. Int J Surg Case Rep. 2014 Jun 5;5(9):584-588. Impact factor: No.
19. Bilateral Sertoli cell adenoma in gonads, associated with serous cystadenoma. Fernández-Vega I, Santos-Juanes J, García-Pravia C. Pol J Patholol. 2014;65(2):154-6
20. Impact factor: 0,8
21. Renal myxoma: an unexpected differential diagnosis. Gómez-González C, Moreno-Nieto V, Vicente-Pablos M, Fernández-Vega I. Pol J Patholol. 2014;65(2):157-9 Impact factor: 0,8
22. Alterations of Heparan Sulfate Proteoglycans in Cancer. Fernández-Vega I, García B, Suárez OG, Castañón S, Quirós LM. J. Glycobiology  Agosto 2014. Impact factor: No.
23. Coexistence of mixed phenotype Creutzfeldt-Jakob disease, Lewy body disease and argyrophilic grain disease plus histological features of possible Alzheimer's disease: A multi-protein disorder in an autopsy case. Fernández-Vega I, Ruiz-Ojeda J, Juste RA, Geijo M, Zarranz JJ, Sánchez Menoyo JL, Vicente-Etxenausia I, Mediavilla-García J, Guerra-Merino I. Neuropathology. 2014 Sep 3. Impact factor: 1.796
24. Huge adrenal hemorrhagic endotelial cyst secondary to an adrenal arteriovenous malformation and mimicking a malignant lesión. Fernández-Vega I, Camacho-Urkaray E, Guerra-Merino I. Endocrine Pathology. 2014, Sep 20. Impact factor: 1.644
25. The role of heparan sulfate proteoglycans in bacterial infections. García B, Fernández-Vega I, Suárez OG, Castañón S, Quirós LM. Journal of Medical Microbiology & Diagnosis. 2014. August. Impact factor: No
26. Bruton's tyrosine kinase (Btk) is a useful marker for Hodgkin and B cell non-Hodgkin lymphoma. Fernández-Vega I, Quirós LM, Santos-Juanes J, Pane-Foix M, Marafioti T. Virchows Arch. 2014 Nov 30. Impact factor: 2,5
27. Hepatic adenomatosis: A rare cause of liver transplant. Fernández-Vega I, Santos-Juanes J, García-Pravia C, Fresno-Forcelledo MF, Rodrigo L. Rev Esp Enferm Dig. 2014 Aug;106(7):494-496. Impact factor: 1,6
28. An acute metabolic insult highly increased postmortem cerebellar autolysis: an autopsy case. Suárez-Pinilla M, Fernández-Vega I. Clin Neuropathol. 2014 Dec 5. Impact factor: 1,34
29. Psoriasis Vulgaris with or without Arthritis and Independent of Disease Severity or Duration Is a Risk Factor for Hypercholesterolemia. Santos-Juanes J, Coto-Segura P, Fernández-Vega I, Armesto S Martínez-Camblor P. Dermatology. 2015 Jan 23. Impact factor: 1,69
30. Prognostic significance of the markers IDH1 and YKL40 related to the subventricular zone. Kelvin Manuel Pińa Batista, Ivan Fernandez Vega, Sayoa Alvarez de Eulate-Beramendi, Julio Cesar Gutierrez Morales, Almaz Kurbanov, Dorisme Asnel, Angela Meilan, Aurora Astudillo. Folia Neuropathologica 03/2015; 53(1):52-59. Impact factor: 1,67
31. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations. Beatriz Tijero, Iñigo Gabilondo, Elena Lezcano, Nuria Teran Villagrá, Verónica Llorens, Javier Ruiz-Martinez, Jose Felix Marti Masso, Carmona M, Maria Rosario Luquin, Koldo Berganzo, Ivan Fernandez, Manuel Fernandez, Juan José Zarranz, Juan Carlos Gómez Esteban. Parkinsonism & Related Disorders 04/2015; Impact factor: 4,13
32. Merkel cell carcinoma and Merkel cell polyomavirus: a systematic review and meta-analysis. J Santos-Juanes, I Fernández-Vega, N Fuentes, C Galache, P Coto-Segura, B Vivanco, A Astudillo, P Martínez-Camblor. British Journal of Dermatology 04/2015. Impact factor: 4,10
33. Anaemia due to gastric haemorrhage by a metastatic Merkel cell carcinoma. Jorge Santos-Juanes, Carmen Palomo, Luis Rodrigo, Iván Fernández-Vega. Przegląd Gastroenterologiczny 05/2015. Impact factor: 0,38
34. 64 Year-Old Woman with Longstanding Migraine. Ivan Fernandez‐Vega, Antonio Saiz, Jorge Santos‐Juanes, Kelvin Piña‐Batista, Maria Daniela Corte‐Torres, Aurora Astudillo. Brain Pathology 05/2015; 25(3). Impact factor: 4,35
35. Sporadic adult-onset leukodystrophy with axonal spheroids and pigmented glia with no mutations in the known targeted genes. Iván Fernández-Vega, Katti Perez de Heredia- Goñi, Jorge Santos-Juanes, M. Goñi Imizcoz, Laura Zaldumbide, Juan Jose Zarranz, Isidro Ferrer. Histopathology. 05/2015; DOI: 10.1111/his.1274. Impact factor: 3,3
36. Heparanase and heparanase 2 display differently deregulation in neuroendocrine tumors, depending on their differentiation grade. García B, García-Suárez O, Fernández-Vega I, Vallina A, Astudillo A, Quirós LM. Histol Histopathol. 2015 Jul 31:11650. [Epub ahead of print]. Impact factor: 2,236
37. Heparan sulfate proteoglycans undergo differential expression alterations in right sided colorectal cancer, depending on their metastatic character. Fernández-Vega I, García-Suárez O, García B, Crespo A, Astudillo A, Quirós LM. BMC Cancer. 2015 Oct 20;15:742. doi: 10.1186/s12885-015-1724-9. Impact factor: 3.36